Sunitinib malate 50 mg/1 (Sunitinib malate CAPSULE) 50 mg/1

Sunitinib malate 50 mg capsules are a medication used for targeted therapy. This oral treatment is designed to inhibit specific proteins involved in cancer cell growth. Learn more about its uses and effects.

Strength

50 mg/1

Pack Size

28 CAPSULE in 1 BOTTLE (16714-679-01)

Manufacturer / TM Owner

NorthStar RxLLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib malate is primarily used in the treatment of certain types of cancer. It works by targeting proteins that help cancer cells grow and spread. Patients often wonder, 'What is Sunitinib malate used for?' This medication is commonly prescribed for advanced renal cell carcinoma and gastrointestinal stromal tumors.

Side Effects

Common effects of Sunitinib malate may include fatigue, nausea, and diarrhea. Some users also experience changes in taste, skin discoloration, or high blood pressure. These effects can vary from person to person and may not affect everyone who takes the medication.

Precautions & Warnings

Sunitinib malate should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

Sunitinib malate may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to consult a healthcare provider before combining Sunitinib malate with other medications, especially those known to interact with CYP3A4 inhibitors or inducers.

Frequently Asked Questions

Sunitinib malate is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and gastrointestinal stromal tumors.

Sunitinib malate is typically taken orally, usually once daily or as directed by a healthcare professional.

Common side effects may include fatigue, nausea, diarrhea, changes in taste, skin discoloration, and high blood pressure.

Sunitinib malate may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Store Sunitinib malate in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.